Elevance Health Inc ELV

$429.69 -0.21 (-0.05%)

Valuation

Market cap
92,882,472,000
Revenue TTM
$199,125,000,000
Net income TTM
$5,662,000,000
P/E (trailing)
14.15
P/E (forward)
14.73
Profit margin
2.84%
Debt to equity
0.69

Trading

Volume
779,100
Avg volume
1,311,120
Day's range
$420.81 – $433.67
Shares out
216,056,000
Stochastic %K
49%
Beta
0.63
Analysts
Moderate Buy
Price target
$478.71

Price

Company profile

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based a...

Show more

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to individual, employer group risk-based and fee-based, BlueCard, Medicare, Medicaid, and FEP members; health products; a broad array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, and supplemental health insurance benefits. The company also operates in the pharmacy services business; and markets and offers pharmacy services, including home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services, as well as infusion services and injectable therapies through ambulatory infusion centers. In addition, it provides healthcare related services and capabilities, including specialty care enablement and utilization management support for specialized clinical domains; behavioral health and comprehensive care management services; palliative care services and management; virtual care; and payment integrity, subrogation, clinical data exchange through its HealthOS platform, research and data, reporting and clinical analytics, information technology, and business process support services, as well as manages home health, post-acute institutional management, and durable medical equipment costs; and supports plans in managing home and community-based services. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brands. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is based in Indianapolis, Indiana.

Industry
Healthcare Plans
Sector
Healthcare
Phone
833 401 1577
Website
https://www.elevancehealth.com
Address
220 Virginia Avenue, Indianapolis, United States

Latest news

Stocktwits

Techdamentals Nov 14, 1:37 AM
The S&P 500 fell 0.40% to 7,561.67 on Friday, November 13, 2026 but finished the week up 2.5%. One number from $ELV's latest report: Medicaid membership was 8.22 million at the end of September 2026, down 4.9% from 8.65 million a year earlier. Is it growing, does it make money, can it pay its bills? The Techdamentals IV Calculator reads the fundamentals in plain English, from the company's own reported numbers. See the fundamentals for yourself and sign up for free. Educational, not advice. https://techdamentals.com/v3/ELV?ref=st
0 replies
SniperAlphaCom Nov 13, 5:49 AM
$ELV — Two bounces off the purple EMA. Is a breakout next? 👀 $ELV has held the purple EMA twice and is now consolidating below resistance, forming a sideways box with signs of tightening price action. Meanwhile, Healthcare continues to show strong relative strength against $SPY. The structure looks promising, but I'd rather see tighter compression before the next move. Can buyers push $ELV through resistance toward new highs? Anyone else watching this setup? 🎯
0 replies
Techdamentals Nov 13, 2:19 AM
$ELV reported earnings on Wednesday, October 21, 2026, before the open. Adjusted earnings per share were $6.99, above the $4.66 to $4.69 analysts expected. The stock fell 1.37% on Wednesday, October 21, 2026, while the S&P 500 rose 0.58%. The headline numbers don't tell you why. The filing might: what the company actually filed, lined up against what analysts expected. See for yourself and sign up for free. Educational, not advice. https://techdamentals.com/v5/ELV/st6?ref=st
0 replies
CamRanhKid Nov 13, 12:52 AM
$ELV dumped some more 😆
0 replies
Techdamentals Nov 12, 1:50 AM
The S&P 500 rose 1.31% to 7,619.38 on Wednesday, November 11, 2026, and the Nasdaq rose 1.60%, as CoreWeave's results lifted tech stocks. One number from $ELV's latest report: Medicaid membership was 8.22 million at the end of September 2026, down 4.9% from 8.65 million a year earlier. Is it growing, does it make money, can it pay its bills? The Techdamentals IV Calculator reads the fundamentals in plain English, from the company's own reported numbers. See the fundamentals for yourself and sign up for free. Educational, not advice. https://techdamentals.com/v3/ELV?ref=st
0 replies
vipulthetrader Nov 11, 5:34 PM
$ELV reaffirms profit forecast for 2026, $22 EPS https://wallstreetbets.com/news/elevance-health-reaffirms-2026-profit-forecast-of-at-least-22-00
0 replies
lemayqc Nov 10, 9:31 PM 0 replies
GTA_Terminal Nov 8, 10:21 PM
$ELV Options Flow Leans to Calls: A Smart-Money Check on the Stock. It's up about 1% from a week ago. Look up any stock's options flow and dark pools on the GTA Terminal, free for 7 days: https://globaltradersacademy.com/start-trial?a=stocktwits&sym=ELV&utm_source=stocktwits&utm_medium=social&utm_campaign=trial&utm_content=ELV Read the full article for the full details: https://globaltradersacademy.com/articles/elevance-health-elv-options-flow-turns-bullish-a-smart-money-check-on-the-stock?utm_source=stocktwits&utm_medium=social
0 replies